Impact of Vitamin D on Chronic Kidney Diseases in Non-Dialysis Patients: A Meta-Analysis of Randomized Controlled Trials

被引:28
作者
Xu, Lijuan [1 ]
Wan, Xuesi [1 ]
Huang, Zhimin [1 ]
Zeng, Fangfang [2 ]
Wei, Guohong [1 ]
Fang, Donghong [1 ]
Deng, Wanping [1 ]
Li, Yanbing [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou, Guangdong, Peoples R China
来源
PLOS ONE | 2013年 / 8卷 / 04期
关键词
GLOMERULAR-FILTRATION-RATE; TYPE-2; DIABETIC-PATIENTS; SECONDARY HYPERPARATHYROIDISM; PARATHYROID-HORMONE; NONDIABETIC NEPHROPATHIES; DOUBLE-BLIND; D-RECEPTOR; PARICALCITOL; ALBUMINURIA; PROTEINURIA;
D O I
10.1371/journal.pone.0061387
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background and Objectives: Recent studies have supported a role for both newer and more established vitamin D compounds in improving proteinuria, although systematic evaluation is lacking. Furthermore, concerns remain regarding the influence of vitamin D on the progression of renal function. We analyzed the efficacy and safety of vitamin D in non-dialysis patients and compared the use of newer versus established vitamin D compounds by performing a meta-analysis of randomized controlled trials. Design: A literature search of PubMed (1975 to September, 2012), EMBASE.com (1966 to September, 2012) and Ovid EBM Reviews (through September, 2012) was conducted. Results: Eighteen studies were eligible for final inclusion; of these, six explored the effects of vitamin D on proteinuria, twelve studied the effects of supplementation on renal function, and fifteen discussed the incidence of hypercalcemia. Compared to the placebo or no interference, both the newer and established vitamin D sterols reduced proteinuria to a similar extent (RR, 2.00; 95% CI, 1.42 to 2.81). No decrease in the glomerular filter rate was observed (SMD, -0.10; 95% CI, -0.24 to 0.03), and the risk for dialysis initiation was 1.48 (95% CI, 0.54 to 4.03) with vitamin D treatment. Additionally, there was an increased risk of hypercalcemia for patients treated with either newer or established vitamin D compounds as compared with the controls (RR, 4.78; 95% CI, 2.20 to 10.37). The head-to-head studies showed no differences in the effects of either newer or established compounds on proteinuria or the risk of hypercalcemia. No serious adverse events were associated with the administration of vitamin D. Conclusions: Vitamin D therapy appears to decrease proteinuria and have no negative influence on renal function in non-dialysis patients. But the occurrence of hypercalcemia should be evaluated when vitamin D is provided. No superiority for newer versus established vitamin D analogue is found.
引用
收藏
页数:14
相关论文
共 50 条
[31]   Vitamin D in Chronic Kidney Disease and Dialysis Patients [J].
Jean, Guillaume ;
Souberbielle, Jean Claude ;
Chazot, Charles .
NUTRIENTS, 2017, 9 (04)
[32]   Efficacy and acceptability of vitamin D supplements for depressed patients: A systematic review and meta-analysis of randomized controlled trials [J].
Srifuengfung, Maytinee ;
Srifuengfung, Somporn ;
Pummangura, Chalermsri ;
Pattanaseri, Keerati ;
Oon-arom, Awirut ;
Srisurapanont, Manit .
NUTRITION, 2023, 108
[33]   Efficacy and Safety of Vitamin D Supplementation in Patients With Systemic Lupus Erythematosus: A Meta-analysis of Randomized Controlled Trials [J].
Zheng, Ronghao ;
Gonzalez, Alex ;
Yue, Jing ;
Wu, Xiaolin ;
Qiu, Ming ;
Gui, Lin ;
Zhu, Songbai ;
Huang, Li .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2019, 358 (02) :104-114
[34]   The effects of vitamin D treatment on glycemic control, serum lipid profiles, and C-reactive protein in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials [J].
Milajerdi, Alireza ;
Ostadmohammadi, Vahidreza ;
Amirjani, Sina ;
Kolahdooz, Fariba ;
Asemi, Zatollah .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (09) :1567-1580
[35]   Burden of Resistant Hypertension in Hypertensive Patients with Non-Dialysis Chronic Kidney Disease [J].
De Nicola, Luca ;
Borrelli, Silvio ;
Gabbai, Francis B. ;
Chiodini, Paolo ;
Zamboli, Pasquale ;
Iodice, Carmela ;
Vitiello, Santo ;
Conte, Giuseppe ;
Minutolo, Roberto .
KIDNEY & BLOOD PRESSURE RESEARCH, 2011, 34 (01) :58-67
[36]   Safety and Efficacy of Spironolactone in Dialysis-Dependent Patients: Meta-Analysis of Randomized Controlled Trials [J].
Liu, Jing ;
Jia, WanYu ;
Yu, Chen .
FRONTIERS IN MEDICINE, 2022, 9
[37]   Effect of Vitamin D Supplementation on Risk of Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [J].
Li, Ziyi ;
Wu, Liangzhi ;
Zhang, Junguo ;
Huang, Xin ;
Thabane, Lehana ;
Li, Guowei .
FRONTIERS IN NUTRITION, 2021, 8
[38]   Vitamin D supplementation in the treatment of polycystic ovary syndrome: A meta-analysis of randomized controlled trials [J].
Zhang, Biyun ;
Yao, Xiuhua ;
Zhong, Xingming ;
Hu, Yang ;
Xu, Jianying .
HELIYON, 2023, 9 (03)
[39]   Influence of vitamin D supplementation on plasma lipid profiles: A meta-analysis of randomized controlled trials [J].
Wang, Hao ;
Xia, Ning ;
Yang, Yang ;
Peng, Dao-Quan .
LIPIDS IN HEALTH AND DISEASE, 2012, 11
[40]   Effect of calcium or vitamin D supplementation on vascular outcomes: A meta-analysis of randomized controlled trials [J].
Mao, Pei-Juan ;
Zhang, Chi ;
Tang, Lan ;
Xian, Yu-Qiong ;
Li, Yan-Song ;
Wang, Wei-Dong ;
Zhu, Xiu-Hua ;
Qiu, Hua-Li ;
He, Jia ;
Zhou, Yu-Hao .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 169 (02) :106-111